Insights

Lithium potential finally recognised by the market

One of the challenging issues in funds management is the discovery and processing of information. Portfolio managers and analysts are subject to  enormous flows of information and one of the  skills required

Reliance Worldwide

Plumbing manufacturer Reliance Worldwide (RWC) closed the first day of trading at $2.95 after the offer was priced at $2.50 by joint lead managers JP Morgan and Macquarie Bank in late April

Oneview – The luck of the Irish

Oneview Healthcare PLC (ONE) listed on the 17th March 2016 at $3.58 per share. Oneview is a Dublin based hospital software business with an emphasis on patient engagement. The company has raised

The Australian Article – Galileo Japan Trust

The Australian article including an interview with Chris Cahill from Quest Asset Partners on Galileo Japan Trust (GJT). Click here to read the article “REIT in retreat as RNY plans to sell its

Galileo Japan Trust delivers for Quest Asset Partners

Quest participated in the  restructuring of Galileo Japan Trust in August 2013 at $1.50 per share. The Trust has always traded well below net tangible asset backing since then while paying an

Solid return for Quest portfolios in 2015

The Quest Australian Equities Concentrated Portfolio delivered a post fee return of 9.4% compared to the market return of 2.8%, an out performance of 6.6% to 31st December 2015. The portfolio now has

Correction? Not really.

The press is currently buzzing with the latest market correction but what has occurred requires a reality check. In late December, specifically on the 16th December, the market took off

Lonsec upgrades Quest Rating

Lonsec has upgraded the rating for the Quest Australian Equities Concentrated portfolio after a recent review. Lonsec provides in depth research into funds of all types including long only, hedge funds, structured products,

Quest return well ahead of market

The Quest Australian Equities Concentrated portfolio has a 1 year return of  8.3%  and is well ahead of the benchmark of  minus  0.5%. The portfolio has benefitted from holding only 5 of

iSelect receives conditional proposal

Quest is a substantial holder in iSelect which today announced that the Board had received a confidential, indicative, non-binding and conditional proposal from an international private equity firm. Unusually,

Insights

Lithium potential finally recognised by the market

One of the challenging issues in funds management is the discovery and processing of information. Portfolio managers and analysts are subject to  enormous flows of information and one of the  skills required

Reliance Worldwide

Plumbing manufacturer Reliance Worldwide (RWC) closed the first day of trading at $2.95 after the offer was priced at $2.50 by joint lead managers JP Morgan and Macquarie Bank in late April

Oneview – The luck of the Irish

Oneview Healthcare PLC (ONE) listed on the 17th March 2016 at $3.58 per share. Oneview is a Dublin based hospital software business with an emphasis on patient engagement. The company has raised

The Australian Article – Galileo Japan Trust

The Australian article including an interview with Chris Cahill from Quest Asset Partners on Galileo Japan Trust (GJT). Click here to read the article “REIT in retreat as RNY plans to sell its

Galileo Japan Trust delivers for Quest Asset Partners

Quest participated in the  restructuring of Galileo Japan Trust in August 2013 at $1.50 per share. The Trust has always traded well below net tangible asset backing since then while paying an

Solid return for Quest portfolios in 2015

The Quest Australian Equities Concentrated Portfolio delivered a post fee return of 9.4% compared to the market return of 2.8%, an out performance of 6.6% to 31st December 2015. The portfolio now has

Correction? Not really.

The press is currently buzzing with the latest market correction but what has occurred requires a reality check. In late December, specifically on the 16th December, the market took off

Lonsec upgrades Quest Rating

Lonsec has upgraded the rating for the Quest Australian Equities Concentrated portfolio after a recent review. Lonsec provides in depth research into funds of all types including long only, hedge funds, structured products,

Quest return well ahead of market

The Quest Australian Equities Concentrated portfolio has a 1 year return of  8.3%  and is well ahead of the benchmark of  minus  0.5%. The portfolio has benefitted from holding only 5 of

iSelect receives conditional proposal

Quest is a substantial holder in iSelect which today announced that the Board had received a confidential, indicative, non-binding and conditional proposal from an international private equity firm. Unusually,